Holding(s) in Company

RNS Number : 4787X

Hikma Pharmaceuticals Plc

25 June 2008

 



Form TR-1 with annex. FSA Version 2.1 updated April 2007

For filings with the FSA include the annex For filings with issuer exclude the annex

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:		Hikma Pharmaceuticals PLC
2. Reason for notification (yes/no)
An acquisition or disposal of voting rights			Yes
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):______________
3. Full name of person(s) subject to notification obligation:	Genesis Asset Managers LLP
4. Full name of shareholder(s) (if different from 3):
5. Date of transaction (and date on which the threshold is crossed or reached if different):	12 June 2008
6. Date on which issuer notified:	23 June 2008
7. Threshold(s) that is/are crossed or reached:	3%

8: Notified Details
A: Voting rights attached to shares
Class/type of shares If possible use ISIN code GB00B0LCW083	Situation previous to the triggering transaction		Resulting situation after the triggering transaction
	Number of shares 5,560,993	Number of voting rights 5,560,993	Number of shares 5,647,800	Number of voting rights		Percentage of voting rights
				Direct 5,647,800	Indirect N/A	Direct  3	Indirect N/A

B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Expiration date	Exercise/ conversion period/date	No. of voting rights that may be acquired (if the instrument exercised/converted)	Percentage of voting rights
N/A

Total (A+B)
Number of voting rights	Percentage of voting rights
5,647,800	3%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Proxy Voting:
10. Name of proxy holder:	N/A
11. Number of voting rights proxy holder will cease to hold:	N/A
12. Date on which proxy holder will cease to hold voting rights:	N/A

13. Additional information:
14 Contact name:	Henry Knowles
15. Contact telephone name:	0207 399 2799

For notes on how to complete form TR-1 please see the FSA website.   

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in shares

A: Identity of the persons or legal entity subject to the notification obligation
Full name  (including legal form of legal entities)
Contact address  (registered office for legal entities)
Phone number & email
Other useful information  (at least legal representative for legal persons)

B: Identity of the notifier, if applicable
Full name
Contact address
Phone number & email
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

 

END

 

 

HOLUVSWRWARNURR